Biotherapies Inc., of Ann Arbor, Mich., elected to its board of directors Tom Trimmer, a co-founder of grapeVINE Technologies...Gliatech Inc., of Cleveland, named John Redmond president and chief operating officer

and Longguang Cao, CelllChip scientist. * Chemical Computing Group Inc., of Montreal, named to its scientific board Jurgen Bajorath, director of computational chemistry & informatics at MDS Panlabs Inc., of Seattle...and Eric Martin, associate director of computational chemistry at Chiron Corp., of Emeryville, Calif. * Chiron Corp., of Emeryville, Calif., named Rajen Dalal president of its blood-screening business. * ChromaVision Medical Systems Inc., of San Juan Capistrano, Calif., added to

and Walter Moore vice president of government affairs. * Genometrix Inc., of The Woodlands, Tex., appointed Michael Hogan chief scientific officer. * Hyal Pharmaceutical Corp., of Mississauga, Ontario, named to its board of directors George deVeber, a nephrologist and biotechnology consultant who initiated the dialysis and transplantation program at Toronto's Western Hospital, and Jan Oudenes, president of Torcan Chemical Ltd. * Hyseq Inc., of Sunnyvale, Calif., made the following

and Paul Vouros, professor of chemistry at Northeastern University. * Arris Pharmaceutical Corp., of South San Francisco, named Ann Welton vice president of biology and preclinical sciences. * Bristol-Myers Squibb Co., of New York, named Elliot Sigal vice president of applied genomics and drug discovery. * Chiron Corp., of Emeryville, Calif., named Linda Short vice president of human resources. * Corvas International Inc., of San Diego, named to its board Douglas Norby, executive vice

and Joan Fusco, vice president of business development. * Recombinant BioCatalysis Inc., of Sharon Hill, Pa., named to its board of directors Daniel Carroll, chairman of The Carroll Group Inc., of Ann Arbor, Mich. * Sepracor Inc., of Marlborough, Mass., named Frederick Graff vice president of sales. * StressGen Biotechnologies Corp., of Victoria, British Columbia, named to its board of directors Steven Mendell, president and CEO of Prizm Pharmaceuticals Inc

ChemTrak Inc., of Sunnyvale, Calif., appointed Edward Covell president and chief operating officer. * Gelman Sciences Inc., of Ann Arbor, Mich., named George Uveges chief financial officer and vice president of administration. * Immunex Corp., of Seattle, named Leonard Stevens to senior vice president of marketing and business development. * L.A.B. Biopharmaceutical Research Internation-al Inc., of Wilmington, N.C., named Richard Musselman head of global business development. * Synbiotics

and John Lucas, a biopharmaceutical industry consultant. * Life Medical Sciences Inc., of Princeton, N.J., named Robert Hickey president and CEO. * T Cell Sciences Inc., of Needham, Mass., made the following appointments: James Grant, CEO...and Norman Gorin, vice president of finance and chief financial officer...Gelman Sciences Inc., of Ann Arbor, Mich., named George Uveges chief financial officer and vice president of administration

and CEO. * Aviron Inc., of Mountain View, Calif., appointed Eric Patzer vice president of development and Paul Mendelman vice president of clinical research and named to its board of directors Jane Shaw, former president and chief operating officer of Alza Corp., of Palo Alto, Calif. * Biogen Inc., of Cambridge, Mass., appointed David Pendergast vice president of quality assurance and quality control. * Coulter Pharmaceutical Inc., of Palo Alto, Calif., named Michael Bigham president and CEO

Aastrom Biosciences Inc., of Ann Arbor, Mich., appointed Todd Simpson vice president of finance and administration and chief financial officer. * Arqule Inc., of Medford, Mass., appointed Eric Gordon president and CEO and John Sorvillo vice president of business development and named as chairman, Joseph Hogan, Arqule's chief scientific founder. * Biogen Inc., of Cambridge, Mass., made the following appointments: David Konys, country manager for Canada...and Michael Ibara, senior drug safety

Aastrom Biosciences Inc., of Ann Arbor, Mich., named Alan Smith vice president of research. * Amylin Pharmaceuticals Inc., of San Diego, appointed Maurizio Denaro senior vice president of research. * Biocircuits Corp., of Sunnyvale, Calif., appointed Jeffrey Green vice president of quality assurance and regulatory affairs. * Celgene Corp., of Warren, N.J., appointed John Jackson chairman and CEO. * Centocor Inc., of Malvern, Pa., named Aris Petropolous vice president of marketing and

He previously was president and CEO at GynoPharma Inc...He is a professor of pharmacy and chemistry at the University of Michigan at Ann Arbor. * ZymoGenetics Inc., of Seattle, appointed Claus Kuhl president

Aastrom Biosciences Inc., of Ann Arbor, Mich., appointed Walter Ogier vice president of marketing. * GenVec Inc., of Rockville, Md., named Imre Kovesdi vice president of discovery research. * Medco Research Inc., of Research Triangle Park, N.C., named Cesare Orlandi executive director of research and development and Adam Derbyshire corporate controller. * Metra Biosystems Inc., of Mountain View, Calif., named Victor Liu senior director of development. * Transcend Therapeutics Inc., of

and Frank Valone, vice president for clinical and regulatory affairs. * Alza Pharmaceuticals Inc., of Palo Alto, Calif., appointed Charles Nau director of government affairs and James Young senior vice president of commercial development. * Aradigm Corp., of Hayward, Calif., named Igor Gonda vice president of research and development. * Biogen Inc., of Cambridge, Mass., named Alphonse Noe associate general counsel. * BioTransplant Inc., of Charlestown, Mass., appointed Frank Spiegel, former

and Peter Carroll, of Tufts University, Boston. * Univax Biologics Inc., of Rockville, Md., appointed Judith Hautala vice president of corporate communications and planning. * Signal Pharmaceuticals Inc., of San Diego, named Bradley Gordon as vice president of finance and chief financial officer. * Matritech Inc., of Cambridge, Mass., appointed Dev Purkayastha, of San Diego-based Idanta Partners Ltd., to the board of directors. * Houghten Pharmaceuticals Inc., of San Diego, named Terence

Aastrom Biosciences Inc., of Ann Arbor, Mich., appointed Bernhard Palsson as vice president of developmental research...Paul Broome was appointed as vice president and medical director for clinical trials and regulatory affairs for Aphton, of Woodland, Calif. (c) 1997 American Health Consultants

Aastrom Biosciences of Ann Arbor, Mich., has named Lynda Dreiling vice president and chief financial officer